Clinical Trial Update: Lung Cancer Symptom Assessment and Management Intervention [Phase 2]

View source ↗

Summary

A Phase 2 trial by Dana-Farber Cancer Institute evaluating a symptom assessment and management intervention for lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED